IGFBP2 and cardiovascular disorder: Researchers discovered that an increased IGFBP2 concentration was significantly and independently associated with long-term cardiovascular disease mortality in patients with PAD, but it should not be regarded as a useful clinical marker in CVD (cardiovascular disease) mortality prediction in this population of patients [14].